相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipid-lowering effect of berberine in human subjects and rats
Yueshan Hu et al.
PHYTOMEDICINE (2012)
A Novel Monocarbonyl Analogue of Curcumin, (1E,4E)-1,5-Bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, Induced Cancer Cell H460 Apoptosis via Activation of Endoplasmic Reticulum Stress Signaling Pathway
Yi Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Activation of AMP-Activated Protein Kinase Is Required for Berberine-Induced Reduction of Atherosclerosis in Mice: The Role of Uncoupling Protein 2
Qilong Wang et al.
PLOS ONE (2011)
20(S)-Ginsenoside Rh2 Noncompetitively Inhibits P-Glycoprotein In Vitro and In Vivo: A Case for Herb-Drug Interactions
Jingwei Zhang et al.
DRUG METABOLISM AND DISPOSITION (2010)
Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats
Yi-Tong Liu et al.
DRUG METABOLISM AND DISPOSITION (2010)
Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines
Wouter F. W. Bierman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signaling
Maren Amasheh et al.
JOURNAL OF CELL SCIENCE (2010)
Development of a Novel Self-Microemulsifying Drug Delivery System for Reducing HIV Protease Inhibitor-Induced Intestinal Epithelial Barrier Dysfunction
Bokai Lei et al.
MOLECULAR PHARMACEUTICS (2010)
Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages
Weibin Zha et al.
PLOS ONE (2010)
Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
Woo Sik Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
Hyun Woo Jeong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
HIV protease inhibitor lopinavir-induced TNF-α and IL-6 expression is coupled to the unfolded protein response and ERK signaling pathways in macrophages
Li Chen et al.
BIOCHEMICAL PHARMACOLOGY (2009)
P-Glycoprotein Mediates Efflux Transport of Darunavir in Human Intestinal Caco-2 and ABCB1 Gene-Transfected Renal LLC-PK1 Cell Lines
Hiromi Fujimoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Up-regulation of P-glycoprotein by HIV Protease Inhibitors in a Human Brain Microvessel Endothelial Cell Line
Jason A. Zastre et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Stephen G. Aller et al.
SCIENCE (2009)
Comparison of ABC transporter modulation by atazanavir in lymphocytes and human brain endothelial cells:: ABC transporters are involved in the atazanavir-limited passage across an in vitro human model of the blood-brain barrier
Laurence Bousquet et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
HIV Therapy, Metabolic Syndrome, and Cardiovascular Risk
Vivian Pao et al.
CURRENT ATHEROSCLEROSIS REPORTS (2008)
Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells
Michael D. Perloff et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein
Caroline Henrike Storch et al.
BIOCHEMICAL PHARMACOLOGY (2007)
C-Phycocyanin inhibits 2-acetylaminofluorene-induced expression of MDR1 in mouse macrophage cells:: ROS mediated pathway determined via combination of experimental and In silico analysis
Karnati R. Roy et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Modulation of human BCRP (ABCG2) activity by anti-HIV drugs
Johanna Weiss et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Human MDR1 and MRP1 recognize berberine as their transport substrate
Nobukazu Shitan et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2007)
HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes
Huiping Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Time-dependent interaction between lopinavir/ritonavir and fexofenadine
Rolf P. G. van Heeswijk et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Atazanavir: Effects on P-glycoprotein transport and CYP3A metabolism in vitro
ES Perloff et al.
DRUG METABOLISM AND DISPOSITION (2005)
Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors
RA Parker et al.
MOLECULAR PHARMACOLOGY (2005)
Signaling pathways mediating gastrointestinal smooth muscle contraction and MLC20 phosphorylation by motilin receptors
J Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
The anti-inflammatory potential of berberine in vitro and in vivo
CL Kuo et al.
CANCER LETTERS (2004)
HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2)
A Gupta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes
SR Penzak et al.
THERAPEUTIC DRUG MONITORING (2004)
Recent pharmacological studies on natural products in China
XZ Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitors
M Richter et al.
PHARMACEUTICAL RESEARCH (2004)
P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers
HJ Maeng et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
The involvement of P-glycoprotein in berberine absorption
GY Pan et al.
PHARMACOLOGY & TOXICOLOGY (2002)
Use of complementary and alternative therapies in HIV-infected patients
J Duggan et al.
AIDS PATIENT CARE AND STDS (2001)
Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture
MD Perloff et al.
AIDS (2000)
分享论文
